. 2013 Mar 8;11:10. doi: 10.1186/1478-4505-11-10
Copyright ©2013 Walwyn; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Figure 1.
Project rNPV for development of first-line TB drug.